Cargando…

Epistasis between the MHC and the RCAα block in primary Sjögren syndrome

OBJECTIVE: The RCAα block (Regulators of Complement Activation, 1q32) contains critical complement regulatory genes such as CR1 and MCP. This study examined RCAα block haplotype associations with both disease susceptibility and diversification of the anti-Ro/La autoantibody response in primary Sjögr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lester, S, McLure, C, Williamson, J, Bardy, P, Rischmueller, M, Dawkins, R L
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565577/
https://www.ncbi.nlm.nih.gov/pubmed/17878210
http://dx.doi.org/10.1136/ard.2007.075044
_version_ 1782159921631985664
author Lester, S
McLure, C
Williamson, J
Bardy, P
Rischmueller, M
Dawkins, R L
author_facet Lester, S
McLure, C
Williamson, J
Bardy, P
Rischmueller, M
Dawkins, R L
author_sort Lester, S
collection PubMed
description OBJECTIVE: The RCAα block (Regulators of Complement Activation, 1q32) contains critical complement regulatory genes such as CR1 and MCP. This study examined RCAα block haplotype associations with both disease susceptibility and diversification of the anti-Ro/La autoantibody response in primary Sjögren syndrome (pSS). METHODS: 115 patients with pSS and 98 controls were included in the study. 93 of 109 (85%) of the patients with pSS were seropositive for Ro/La autoantibodies. The Genomic Matching Technique (GMT) was used to define RCAα block ancestral haplotypes (AH). RESULTS: RCAα block haplotypes, AH1 and AH3, were both associated with autoantibody-positive pSS (p = 0.0003). Autoantibody associations with both HLA DR3 and DR15 have been previously defined. There was an epistatic interaction (p = 0.023) between RCAα AH1 and HLA DR3, and this genotypic combination was present in 48% of autoantibody-positive patients with pSS compared with 8% of controls. This epistasis is most simply attributable to an interaction between C4 and its receptor, CR1, encoded within the RCAα block. Both DR3 and a relative C4 deficiency are carried on the major histocompatibility complex 8.1 ancestral haplotype. Only four of 92 (4%) autoantibody-positive patients with pSS did not carry any risk RCAα or HLA haplotype, compared with 36 of 96 (38%) controls, and there were differences in haplotype frequencies within autoantibody subsets of pSS. CONCLUSIONS: Normal population variation in the RCAα block, in addition to the major histocompatibility complex, contributes genetic susceptibility to systemic autoimmune disease and the autoantibody response. This finding provides evidence for the role of regulation of complement activation in disease pathogenesis.
format Text
id pubmed-2565577
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-25655772008-10-24 Epistasis between the MHC and the RCAα block in primary Sjögren syndrome Lester, S McLure, C Williamson, J Bardy, P Rischmueller, M Dawkins, R L Ann Rheum Dis Extended Reports OBJECTIVE: The RCAα block (Regulators of Complement Activation, 1q32) contains critical complement regulatory genes such as CR1 and MCP. This study examined RCAα block haplotype associations with both disease susceptibility and diversification of the anti-Ro/La autoantibody response in primary Sjögren syndrome (pSS). METHODS: 115 patients with pSS and 98 controls were included in the study. 93 of 109 (85%) of the patients with pSS were seropositive for Ro/La autoantibodies. The Genomic Matching Technique (GMT) was used to define RCAα block ancestral haplotypes (AH). RESULTS: RCAα block haplotypes, AH1 and AH3, were both associated with autoantibody-positive pSS (p = 0.0003). Autoantibody associations with both HLA DR3 and DR15 have been previously defined. There was an epistatic interaction (p = 0.023) between RCAα AH1 and HLA DR3, and this genotypic combination was present in 48% of autoantibody-positive patients with pSS compared with 8% of controls. This epistasis is most simply attributable to an interaction between C4 and its receptor, CR1, encoded within the RCAα block. Both DR3 and a relative C4 deficiency are carried on the major histocompatibility complex 8.1 ancestral haplotype. Only four of 92 (4%) autoantibody-positive patients with pSS did not carry any risk RCAα or HLA haplotype, compared with 36 of 96 (38%) controls, and there were differences in haplotype frequencies within autoantibody subsets of pSS. CONCLUSIONS: Normal population variation in the RCAα block, in addition to the major histocompatibility complex, contributes genetic susceptibility to systemic autoimmune disease and the autoantibody response. This finding provides evidence for the role of regulation of complement activation in disease pathogenesis. BMJ Publishing Group 2008-06 2007-09-18 /pmc/articles/PMC2565577/ /pubmed/17878210 http://dx.doi.org/10.1136/ard.2007.075044 Text en © Lester et al 2008 http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Extended Reports
Lester, S
McLure, C
Williamson, J
Bardy, P
Rischmueller, M
Dawkins, R L
Epistasis between the MHC and the RCAα block in primary Sjögren syndrome
title Epistasis between the MHC and the RCAα block in primary Sjögren syndrome
title_full Epistasis between the MHC and the RCAα block in primary Sjögren syndrome
title_fullStr Epistasis between the MHC and the RCAα block in primary Sjögren syndrome
title_full_unstemmed Epistasis between the MHC and the RCAα block in primary Sjögren syndrome
title_short Epistasis between the MHC and the RCAα block in primary Sjögren syndrome
title_sort epistasis between the mhc and the rcaα block in primary sjögren syndrome
topic Extended Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565577/
https://www.ncbi.nlm.nih.gov/pubmed/17878210
http://dx.doi.org/10.1136/ard.2007.075044
work_keys_str_mv AT lesters epistasisbetweenthemhcandthercaablockinprimarysjogrensyndrome
AT mclurec epistasisbetweenthemhcandthercaablockinprimarysjogrensyndrome
AT williamsonj epistasisbetweenthemhcandthercaablockinprimarysjogrensyndrome
AT bardyp epistasisbetweenthemhcandthercaablockinprimarysjogrensyndrome
AT rischmuellerm epistasisbetweenthemhcandthercaablockinprimarysjogrensyndrome
AT dawkinsrl epistasisbetweenthemhcandthercaablockinprimarysjogrensyndrome